2012
DOI: 10.5603/nmr.2012.0006
|View full text |Cite
|
Sign up to set email alerts
|

Equilibrium radionuclide ventriculography in the assessment of cardiotoxicity of chemotherapy and chemoradiotherapy in patients with breast cancer

Abstract: BACKGROUND: Multidrug chemotherapy increases the efficacy of the treatment, but at the same time rises its cardiotoxicity. The majority of cardiac complications are caused by anthracyclines. Radiation therapy may intensify cardiotoxicity. The aim of this study was to determine early changes of cardiac function using radionuclide ventriculography in patients with breast cancer and to compare the toxicity of AC and AT chemotherapy programs. MATERIAL AND METHODS: The study included 71 patients with breast cancer … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 5 publications
0
9
0
Order By: Relevance
“…[52][53][54] Among the rapidly increasing variety of anti-cancer drugs used in breast cancer treatment, the anthracyclines and the monoclonal antibody trastuzumab, are the agents with well-known cardiotoxicity. 53,55 Anthracycline chemotherapy causes cumulative dose-dependent cardiotoxicity with direct and irreversible cellular damage to myocytes, which can result in congestive heart failure and even cardiac death. 52 Trastuzumab can induce high cardiotoxicity rates particularly when combined with anthracyclines.…”
Section: Tc-99m Multigated Radionuclide Angiographymentioning
confidence: 99%
See 4 more Smart Citations
“…[52][53][54] Among the rapidly increasing variety of anti-cancer drugs used in breast cancer treatment, the anthracyclines and the monoclonal antibody trastuzumab, are the agents with well-known cardiotoxicity. 53,55 Anthracycline chemotherapy causes cumulative dose-dependent cardiotoxicity with direct and irreversible cellular damage to myocytes, which can result in congestive heart failure and even cardiac death. 52 Trastuzumab can induce high cardiotoxicity rates particularly when combined with anthracyclines.…”
Section: Tc-99m Multigated Radionuclide Angiographymentioning
confidence: 99%
“…52 Evaluation of global LV systolic function and diastolic performance indexes using RNA has proven effective for early assessment of functional changes after chemotherapy compared to baseline, emphasising that serial imaging is critical at all treatment stages to assess patient prognosis. 53,59 A reduction in the peak fill rate as measured by multigated RNA indicates worsening diastolic function, a parameter that is often impaired before declining systolic function in anthracycline-induced cardiotoxicity and more importantly, is an early indication of compromised cardiac function. 56,63 Small or moderate cases of pericardial effusions do not compromise LVEF but may induce comorbidities such as compromised breathing, induced chest pain and abdominal fullness, and difficulty swallowing.…”
Section: Tc-99m Multigated Radionuclide Angiographymentioning
confidence: 99%
See 3 more Smart Citations